Détention brevets de la classe A61K 9/1272

Brevets de cette classe: 328

Historique des publications depuis 10 ans

0
5
4
5
14
20
19
12
126
78
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Translate bio, Inc.
413
23
Modernatx, Inc.
1282
11
BioNTech SE
784
8
The Regents of the University of California
20590
7
FUJIFILM Corporation
30327
6
The Trustees of the University of Pennsylvania
4403
6
Orna Therapeutics, Inc.
69
6
Massachusetts Institute of Technology
10204
5
Alnylam Pharmaceuticals, Inc.
1170
5
Sanofi Pasteur Inc.
279
5
Flagship Pioneering Innovations VI, LLC.
573
5
NanoVation Therapeutics Inc.
81
4
Metagenomi Therapeutics, Inc.
60
4
Genentech, Inc.
4090
3
Nitto Denko Corporation
8486
3
Life Technologies Corporation
3392
3
University of Florida Research Foundation, Inc.
4159
3
Acuitas Therapeutics Inc.
133
3
Factor Bioscience Inc.
108
3
The United States Government AS represented by The Department of Veterans Affairs
1307
3
Autres propriétaires 212